Navigation Links
Prix Galien USA to Launch a Health Care Dialogue Among World-Leading Innovators in Science, Economics and Biotech
Date:9/22/2009

Panelists to Explore the Role of Innovation in Global Public Health

NEW YORK, Sept. 22 /PRNewswire-USNewswire/ -- The committee for the Prix Galien USA, the equivalent to the Nobel Prize for pharmaceutical research and development, will host an unprecedented discussion of how innovative science and clinical research can improve health care across the U.S. and around the world.

The event will feature Walter Gilbert, M.D., founder of Biogen and a member of the Prix Galien USA committee; Leonard Bell, M.D., president and CEO of Alexion Pharmaceuticals; a patient living with the ultra-rare disease paroxysmal nocturnal hemoglobinuria (PNH); as well as the recipients of the 2009 Prix Galien Pro Bono Humanum Award, Barry Bloom, Ph.D., and Jeffrey Sachs, Ph.D. The event will be held at the American Museum of Natural History in New York City on September 30 at 2:30 p.m., preceding the 2009 Prix Galien USA gala awards ceremony.

Moderated by Prix Galien USA Committee Chair Gerald Weissmann, M.D., the discussion will examine the full spectrum of health and disease -- from the world's major pandemics to ultra-rare diseases -- and the role innovation plays in improving health care. Panelists will analyze the applications of basic biomedical science and economics that have been used to address the world's biggest problems and have the potential to improve human health and wellness.

WHEN: Wednesday, September 30, 2009, 2:30 p.m.

WHERE: The Portrait Room

American Museum of Natural History

Central Park West at 79th Street, New York

Enter through the Carriage Portico, under the main stairs

Contact Rachael Siefert at rsiefert@vancomm.com to RSVP for the event.

WHO: Dr. Gerald Weissmann, chair of the Prix Galien USA committee, will moderate the press event to feature:

  • Dr. Barry Bloom, Joan L. and Julius H. Jacobson Professor of Public Health, Harvard School of Public Health, 2009 Pro Bono Humanum Recipient
  • Dr. Jeffrey Sachs, director of the Earth Institute, Columbia University, 2009 Pro Bono Humanum Recipient
  • Dr. Walter Gilbert, Nobel Laureate and Prix Galien USA committee member
  • Dr. Leonard Bell, president and CEO of Alexion Pharmaceuticals, will address the critical need for ongoing medical innovation and access to therapies for patients with rare disorders and will be joined by a patient who will share their perspective on living with a rare disease.

The Prix Galien USA Award (www.prix-galien-usa.com) recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines that improve the human condition, and is considered the industry's highest accolade for pharmaceutical research and development. The 11-member award committee includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journal.

    CONTACT:
    Brandi Horton
    202-331-4323
    bhorton@vancomm.com


'/>"/>
SOURCE Prix Galien USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
2. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
3. Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
4. Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee
5. Abortion Opponents Launch Massive Grassroots Mobilization in 212 Cities
6. Childrens Hospitals and Clinics of Minnesota Launches H1N1 Outreach Effort with Minneapolis and Saint Paul Public Schools
7. Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition Report
8. Video: Anthem Blue Cross and the California Governors Council on Physical Fitness and Sports Launch the Live Like a Champion Tour
9. NFL Network Launches 2009 National Keep Gym in School Campaign at New York City Middle School; Effort Will Give More U.S. Students Access to Quality Physical Education
10. Advantage Business Media Launches Enhanced Websites
11. Integrated Benefits Institute Launches Productivity Modeling Tools to Help Employers Estimate the Impact of Absent Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer ... futuristic vision of its owner and founder. As Oat is recognized globally as one ... he knows personally as he believes it is a move to sow the seed ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... medical office in Petaluma, located at 167 Lynch Creek Way. The Petaluma office ... SRO sports medicine and rehabilitation services and on-site x-ray services. Two multi-specialist ...
(Date:1/20/2017)... ... 20, 2017 , ... A new partnership between Goodwill® and Roadie, Inc. aims ... need, from clothes to couches to dressers and bicycles. Roadie — the national on-the-way ... nearest Goodwill donation center through February 28th. , “January is an exciting time ...
(Date:1/20/2017)... ... 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to developing ... successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition ... provide its products to all clients at reasonable prices. At the ECRM trade show, ...
(Date:1/20/2017)... ... 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years of Betsy’s ... clinical trial has been life-saving as she has been on the trial for ... was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but a year ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... studies the current and future scenario of the global ... for rising opioid consumption. Severe chronic constipation is a ... resistance to traditional laxatives. Hence, novel targeted therapy has ... of OIC sufferers, launch of targeted medicines, and growing ...
(Date:1/19/2017)... 2017 According to a study conducted by ... to witness a CAGR of 6.5% during the forecast period 2016-2024. ... continue to be the leading market for cryotherapy globally during the ... Highlights ... ensuring affordable and adequate supply of gas in order to provide ...
(Date:1/19/2017)... Jan. 19, 2017  Sensus Healthcare, Inc. (NASDAQ: ... specializing in the treatment of non-melanoma skin cancers ... superficial radiation therapy, today announced that it will ... financial results on Thursday, February 2, 2017 after the ... a conference call with the investment community on Thursday, ...
Breaking Medicine Technology: